-
Sanofi's 2023 Prilimumab Revenue Reaches a New High and the Growth Rate of the Chinese Market Slows Down
On February 1st, Sanofi released its 2023 financial report, stating that its annual sales reached 43.07 billion euros (46.52 billion US dollars, equivalent to 1.08 US dollars at the current exchange ...